Financial News
Latest News about MRK
Recent news which mentions MRK
After Failed Prostate Cancer Study Merck's Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study
March 21, 2024
From Benzinga
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
March 21, 2024
From Motley Fool
Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal Conjugate Vaccine
March 19, 2024
From Benzinga
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
March 18, 2024
From Benzinga
Newly Diagnosed Cervical Cancer Patients - Merck's Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival
March 15, 2024
From Benzinga
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
March 14, 2024
From Benzinga
7 Dow Darlings for Investors to Buy for March Market Madness
March 13, 2024
Tags
NYSE:MRK,NASDAQ:AMZN,NASDAQ:WBA,NYSE:DB,NASDAQ:MSFT,NYSE:CRM,NYSE:CRM,NYSE:IBM
DB
Stocks to Buy
From InvestorPlace
From Benzinga
From InvestorPlace
What's Going On With Moderna Stock On Monday?
March 11, 2024
From Benzinga
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
March 09, 2024
From Motley Fool
From InvestorPlace
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029
March 07, 2024
From Benzinga
Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead's and Merck's Combo Therapy
March 06, 2024
From Benzinga
Biogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers
March 06, 2024
From Benzinga
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
March 05, 2024
From Benzinga
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
March 05, 2024
From Benzinga
The Top 3 Dow Stocks to Buy in March 2024
March 04, 2024
From InvestorPlace
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
From Motley Fool
From Benzinga
7 Timeless Stocks to Invest in for 2024
March 01, 2024
From InvestorPlace
Critical Insights From Merck & Co Analyst Ratings: What You Need To Know
February 29, 2024
Tickers
MRK
From Benzinga
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
From Motley Fool
From Benzinga
From Benzinga
3 Long-Term Winners from Charles Schwab’s Top Picks
February 27, 2024
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
